Literature DB >> 25315433

Opportunities and challenges for repair of macrovascular disease using circulating blood-derived progenitor cells.

Mary R Loeken1.   

Abstract

There are currently few solutions for diabetic vascular disease that involve repair of damaged tissues. The manuscript by Porat et al. in this issue, suggests a possible method to use a patient's own circulating blood cells to provide progenitors to repair damaged vascular tissues.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Mesh：

Year:  2014        PMID： 25315433      PMCID： PMC4222573          DOI： 10.1002/dmrr.2564

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN： 1520-7552            Impact factor:   4.876


  15 in total

1.  Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.

Authors:  E E Vaughan; A Liew; K Mashayekhi; P Dockery; J McDermott; B Kealy; A Flynn; A Duffy; C Coleman; A O'Regan; F P Barry; T O'Brien
Journal:  Cell Transplant       Date:  2012-02-02       Impact factor: 4.064

Review 2.  Management of ischemic diabetic foot.

Authors:  C Caravaggi; R Ferraresi; M Bassetti; A B Sganzaroli; P Galenda; S Fattori; R De Prisco; D Simonetti; F Bona
Journal:  J Cardiovasc Surg (Torino)       Date:  2013-12       Impact factor: 1.888

Review 3.  Diabetic vascular disease: characteristics of vascular disease unique to the diabetic patient.

Authors:  Gary W Gibbons; Palma M Shaw
Journal:  Semin Vasc Surg       Date:  2012-06       Impact factor: 1.000

4.  Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.

Authors:  A Raiter; Z Bechor; M Kleiman; D Leshem-Lev; A Battler; B Hardy
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-03-11       Impact factor: 7.069

5.  Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study.

Authors:  Elbert S Huang; Neda Laiteerapong; Jennifer Y Liu; Priya M John; Howard H Moffet; Andrew J Karter
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

Review 6.  Diabetes, vascular complications and antiplatelet therapy: open problems.

Authors:  A M Cerbone; N Macarone-Palmieri; G Saldalamacchia; A Coppola; G Di Minno; A A Rivellese
Journal:  Acta Diabetol       Date:  2008-12-02       Impact factor: 4.280

7.  Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells.

Authors:  Laura Shin; Daniel A Peterson
Journal:  Stem Cells Transl Med       Date:  2012-12-21       Impact factor: 6.940

8.  Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway.

Authors:  Gaia Spinetti; Daniela Cordella; Orazio Fortunato; Elena Sangalli; Sergio Losa; Ambra Gotti; Franco Carnelli; Francesco Rosa; Stefano Riboldi; Fausto Sessa; Elisa Avolio; Antonio Paolo Beltrami; Constanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2012-12-18       Impact factor: 17.367

9.  Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats.

Authors:  Jiangbo Wan; Liulu Xia; Wenjia Liang; Yi Liu; Qian Cai
Journal:  J Diabetes Res       Date:  2013-04-09       Impact factor: 4.011

10.  Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.

Authors:  Maria G Roubelakis; Grigorios Tsaknakis; Kalliopi I Pappa; Nicholas P Anagnou; Suzanne M Watt
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.